[F1] Flash Talks (Odd No.)

13:47 〜 13:48

[F-35] Development of IL-12-expressing HSV-1 for malignant melanoma

*Hitomi Nakamura^1,2, Miwako Iwai¹, Ryuhei Okuyama², Tomoki Todo¹ (1. Project Division of Oncolytic Virus Development, The Institute of Medical Science, The University of Tokyo (Japan), 2. The Department of Dermatology, Shinshu University School of Medicine (Japan))

キーワード：

Oncolytic virus therapy、Herpes simplex virus type 1 (HSV-1)、Interleukin 12 (IL-12)、Malignant melanoma、In situ cancer vaccine

閲覧にはパスワードが必要です

ログイン

または